UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 41

Sortiert nach

Heterotrimerization of the Growth Factor Receptors erbB2, erbB3, and Insulin-like Growth Factor-I Receptor in Breast Cancer Cells Resistant to Herceptin

Cancer research (Chicago, Ill.), 2010-02, Vol.70 (3), p.1204-1214

2010

Link zum Volltext

Verfügbarkeit prüfen

Genistein targets the cancerous inhibitor of PP2A to induce growth inhibition and apoptosis in breast cancer cells

International journal of oncology, 2016-09, Vol.49 (3), p.1203-1210

2016

Link zum Volltext

Verfügbarkeit prüfen

Survival signaling by notch1 : Mammalian target of rapamycin (mTOR)-dependent inhibition of p53

Cancer research (Chicago, Ill.), 2006-05, Vol.66 (9), p.4715-4724

2006

Link zum Volltext

Verfügbarkeit prüfen

Metformin Selectively Targets Tumor-Initiating Cells in ErbB2-Overexpressing Breast Cancer Models

Cancer prevention research (Philadelphia, Pa.), 2014-02, Vol.7 (2), p.199-210

2014

Link zum Volltext

Verfügbarkeit prüfen

Downregulation of erbB3 abrogates erbB2‐mediated tamoxifen resistance in breast cancer cells

International journal of cancer, 2007-05, Vol.120 (9), p.1874-1882

2007

Link zum Volltext

Verfügbarkeit prüfen

Low-dose dietary phytoestrogen abrogates tamoxifen-associated mammary tumor prevention

Cancer research (Chicago, Ill.), 2005-02, Vol.65 (3), p.879-886

2005

Link zum Volltext

Verfügbarkeit prüfen

Short-term early exposure to lapatinib confers lifelong protection from mammary tumor development in MMTV-erbB-2 transgenic mice

Journal of experimental & clinical cancer research, 2017-01, Vol.36 (1), p.6, Article 6

2017

Link zum Volltext

Verfügbarkeit prüfen

Resveratrol induces apoptosis in breast cancer cells by E2F1-mediated up-regulation of ASPP1

Oncology reports, 2011-06, Vol.25 (6), p.1713-1719

2011

Link zum Volltext

Verfügbarkeit prüfen

Genistein induces enhanced growth promotion in ER-positive/erbB-2-overexpressing breast cancers by ER–erbB-2 cross talk and p27/kip1 downregulation

Carcinogenesis (New York), 2010-04, Vol.31 (4), p.695-702

2010

Link zum Volltext

Verfügbarkeit prüfen

Bcl-2 overexpression sensitizes MCF-7 cells to genistein by multiple mechanisms

International journal of oncology, 2007-10, Vol.31 (4), p.867-874

2007

Link zum Volltext

Verfügbarkeit prüfen

Cell density-dependent regulation of p73 in breast cancer cells

International journal of oncology, 2009-12, Vol.35 (6), p.1429-1434

2009

Link zum Volltext

Verfügbarkeit prüfen

Estrogenic Promotion of ErbB2 Tyrosine Kinase Activity in Mammary Tumor Cells Requires Activation of ErbB3 Signaling

Molecular cancer research, 2009-11, Vol.7 (11), p.1882-1892

2009

Link zum Volltext

Verfügbarkeit prüfen

Caspase expression profile and functional activity in a panel of breast cancer cell lines

Oncology reports, 2007-05, Vol.17 (5), p.1229-1235

2007

Link zum Volltext

Verfügbarkeit prüfen

Ganetespib induces G2/M cell cycle arrest and apoptosis in gastric cancer cells through targeting of receptor tyrosine kinase signaling

International journal of oncology, 2017-09, Vol.51 (3), p.967-974

2017

Link zum Volltext

Verfügbarkeit prüfen

Hormonal and dietary modulation of mammary carcinogenesis in mouse mammary tumor virus-c-erbB-2 transgenic mice

Cancer research (Chicago, Ill.), 2003-05, Vol.63 (10), p.2425-2433

2003

Link zum Volltext

Verfügbarkeit prüfen

The anti-erbB3 antibody MM-121/SAR256212 in combination with trastuzumab exerts potent antitumor activity against trastuzumab-resistant breast cancer cells

Molecular cancer, 2013-11, Vol.12 (1), p.134-134, Article 134

2013

Link zum Volltext

Verfügbarkeit prüfen

Alcohol promotes migration and invasion of triple‐negative breast cancer cells through activation of p38 MAPK and JNK

Molecular carcinogenesis, 2017-03, Vol.56 (3), p.849-862

2017

Link zum Volltext

Verfügbarkeit prüfen

HDAC inhibitor SNDX-275 enhances efficacy of trastuzumab in erbB2-overexpressing breast cancer cells and exhibits potential to overcome trastuzumab resistance

Cancer letters, 2011-08, Vol.307 (1), p.72-79

2011

Link zum Volltext

Verfügbarkeit prüfen

Buformin inhibits the stemness of erbB-2-overexpressing breast cancer cells and premalignant mammary tissues of MMTV-erbB-2 transgenic mice

Journal of experimental & clinical cancer research, 2017-02, Vol.36 (1), p.28, Article 28

2017

Link zum Volltext

Verfügbarkeit prüfen

Phenformin inhibits growth and epithelial-mesenchymal transition of ErbB2-overexpressing breast cancer cells through targeting the IGF1R pathway

Oncotarget, 2017-09, Vol.8 (36), p.60342-60357

2017

Link zum Volltext

Verfügbarkeit prüfen

DMBA promotes ErbB2‑mediated carcinogenesis via ErbB2 and estrogen receptor pathway activation and genomic instability

Oncology reports, 2018-09, Vol.40 (3), p.1632-1640

2018

Link zum Volltext

Verfügbarkeit prüfen

Activation of cancerous inhibitor of PP2A (CIP2A) contributes to lapatinib resistance through induction of CIP2A-Akt feedback loop in ErbB2-positive breast cancer cells

Oncotarget, 2017-08, Vol.8 (35), p.58847-58864

2017

Link zum Volltext

Verfügbarkeit prüfen

Characterization and chromosomal instability of novel derived cell lines from a wt-erbB-2 transgenic mouse model

Carcinogenesis (New York), 2003-04, Vol.24 (4), p.659-664

2003

Link zum Volltext

Verfügbarkeit prüfen

Effects of receptor tyrosine kinase inhibitor A47 on estrogen and growth factor-dependent breast cancer cell proliferation and apoptosis in vitro

Journal of surgical oncology, 2002-01, Vol.79 (1), p.17-29

2002

Link zum Volltext

Verfügbarkeit prüfen

Activation of a Cysteine Protease in MCF-7 and T47D Breast Cancer Cells during β-Lapachone-Mediated Apoptosis

Experimental cell research, 2000-03, Vol.255 (2), p.144-155

2000

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 41

Suche als RSS-Feed

Aktive Filter

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(41)

Publikationsform

Artikel
(41)

Sprache

Englisch
(41)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Heterotrimerization of the Growth Factor Receptors erbB2, erbB3, and Insulin-like Growth Factor-I Receptor in Breast Cancer Cells Resistant to Herceptin

Genistein targets the cancerous inhibitor of PP2A to induce growth inhibition and apoptosis in breast cancer cells

Survival signaling by notch1 : Mammalian target of rapamycin (mTOR)-dependent inhibition of p53

Metformin Selectively Targets Tumor-Initiating Cells in ErbB2-Overexpressing Breast Cancer Models

Downregulation of erbB3 abrogates erbB2‐mediated tamoxifen resistance in breast cancer cells

Low-dose dietary phytoestrogen abrogates tamoxifen-associated mammary tumor prevention

Short-term early exposure to lapatinib confers lifelong protection from mammary tumor development in MMTV-erbB-2 transgenic mice

Resveratrol induces apoptosis in breast cancer cells by E2F1-mediated up-regulation of ASPP1

Genistein induces enhanced growth promotion in ER-positive/erbB-2-overexpressing breast cancers by ER–erbB-2 cross talk and p27/kip1 downregulation

Bcl-2 overexpression sensitizes MCF-7 cells to genistein by multiple mechanisms

Cell density-dependent regulation of p73 in breast cancer cells

Estrogenic Promotion of ErbB2 Tyrosine Kinase Activity in Mammary Tumor Cells Requires Activation of ErbB3 Signaling

Caspase expression profile and functional activity in a panel of breast cancer cell lines

Ganetespib induces G2/M cell cycle arrest and apoptosis in gastric cancer cells through targeting of receptor tyrosine kinase signaling

Hormonal and dietary modulation of mammary carcinogenesis in mouse mammary tumor virus-c-erbB-2 transgenic mice

The anti-erbB3 antibody MM-121/SAR256212 in combination with trastuzumab exerts potent antitumor activity against trastuzumab-resistant breast cancer cells

Alcohol promotes migration and invasion of triple‐negative breast cancer cells through activation of p38 MAPK and JNK

HDAC inhibitor SNDX-275 enhances efficacy of trastuzumab in erbB2-overexpressing breast cancer cells and exhibits potential to overcome trastuzumab resistance

Buformin inhibits the stemness of erbB-2-overexpressing breast cancer cells and premalignant mammary tissues of MMTV-erbB-2 transgenic mice

Phenformin inhibits growth and epithelial-mesenchymal transition of ErbB2-overexpressing breast cancer cells through targeting the IGF1R pathway

DMBA promotes ErbB2‑mediated carcinogenesis via ErbB2 and estrogen receptor pathway activation and genomic instability

Activation of cancerous inhibitor of PP2A (CIP2A) contributes to lapatinib resistance through induction of CIP2A-Akt feedback loop in ErbB2-positive breast cancer cells

Characterization and chromosomal instability of novel derived cell lines from a wt-erbB-2 transgenic mouse model

Effects of receptor tyrosine kinase inhibitor A47 on estrogen and growth factor-dependent breast cancer cell proliferation and apoptosis in vitro

Activation of a Cysteine Protease in MCF-7 and T47D Breast Cancer Cells during β-Lapachone-Mediated Apoptosis

Aktive Filter

Suchergebnisse filtern